<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28416701</article-id>
<article-id pub-id-type="pmc">5422768</article-id>
<article-id pub-id-type="publisher-id">201617259</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1617259114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease</article-title>
<alt-title alt-title-type="short">Disease phenotypes in p.A53T αSyn human neurons</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kouroupi</surname>
<given-names>Georgia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taoufik</surname>
<given-names>Era</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vlachos</surname>
<given-names>Ioannis S.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsioras</surname>
<given-names>Konstantinos</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Antoniou</surname>
<given-names>Nasia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Papastefanaki</surname>
<given-names>Florentia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chroni-Tzartou</surname>
<given-names>Dafni</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wrasidlo</surname>
<given-names>Wolfgang</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bohl</surname>
<given-names>Delphine</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-9587-6288</contrib-id>
<name>
<surname>Stellas</surname>
<given-names>Dimitris</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Politis</surname>
<given-names>Panagiotis K.</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vekrellis</surname>
<given-names>Kostas</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Papadimitriou</surname>
<given-names>Dimitra</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>i</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stefanis</surname>
<given-names>Leonidas</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>j</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bregestovski</surname>
<given-names>Piotr</given-names>
</name>
<xref ref-type="aff" rid="aff11">
<sup>k</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hatzigeorgiou</surname>
<given-names>Artemis G.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Masliah</surname>
<given-names>Eliezer</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsas</surname>
<given-names>Rebecca</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Neurobiology, <institution>Hellenic Pasteur Institute</institution>, 11521 Athens, <country>Greece</country>;</aff>
<aff id="aff2"><sup>b</sup>DIANA-Lab, <institution>Hellenic Pasteur Institute</institution>, 11521 Athens, <country>Greece</country>;</aff>
<aff id="aff3"><sup>c</sup>Department of Neurology, Aeginition Hospital, <institution>University of Athens Medical School</institution>, 11528 Athens, <country>Greece</country>;</aff>
<aff id="aff4"><sup>d</sup>Department of Neurosciences, <institution>University of California, San Diego</institution>, La Jolla, CA 92093;</aff>
<aff id="aff5"><sup>e</sup><institution>Institut Pasteur</institution>, 75015 Paris, <country>France</country>;</aff>
<aff id="aff6"><sup>f</sup>Department of Cancer Biology, <institution>Biomedical Research Foundation of the Academy of Athens</institution>, 11527 Athens, <country>Greece</country>;</aff>
<aff id="aff7"><sup>g</sup>Center for Basic Research, <institution>Biomedical Research Foundation of the Academy of Athens</institution>, 11527 Athens, <country>Greece</country>;</aff>
<aff id="aff8"><sup>h</sup>Center of Clinical Research, Experimental Surgery and Translational Research, <institution>Biomedical Research Foundation of the Academy of Athens</institution>, 11527 Athens, <country>Greece</country>;</aff>
<aff id="aff9"><sup>i</sup>Neurology Clinic, <institution>Henry Dunant Hospital Center</institution>, 11526 Athens, <country>Greece</country>;</aff>
<aff id="aff10"><sup>j</sup>Second Department of Neurology, <institution>University of Athens Medical School</institution>, 11527 Athens, <country>Greece</country>;</aff>
<aff id="aff11"><sup>k</sup>Aix-Marseille Université, INSERM, <institution>Institut de Neurosciences des Systèmes</institution>, 13005 Marseille, <country>France</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>2</sup>To whom correspondence should be addressed. Email: <email>rmatsa@pasteur.gr</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved March 24, 2017 (received for review October 18, 2016)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: G.K., E.T., and R.M. designed research; G.K., E.T., I.S.V., K.T., N.A., F.P., D.C.-T., D.S., P.K.P., and P.B. performed research; D.B. oversaw iPSC generation; A.G.H. supervised the bioinformatics analysis; W.W. and E.M. provided small-molecule inhibitors of αSyn aggregation; K.V., D.P., and L.S. provided patient fibroblasts; G.K., W.W., K.V., D.P., L.S., and E.M. contributed new reagents/analytic tools; G.K., E.T., I.S.V., N.A., F.P., P.B., A.G.H., and R.M. analyzed data; and G.K., E.T., and R.M. wrote the paper.</p>
</fn>
<fn fn-type="present-address" id="fn1">
<p><sup>1</sup>Present address: Institut du Cerveau et de la Moelle épinière, INSERM U 1127, CNRS UMR-7225, Université Pierre et Marie Curie, Hôpital de la Pitié-Salpêtrière, 75013 Paris, France.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>2</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>114</volume>
<issue>18</issue>
<fpage>E3679</fpage>
<lpage>E3688</lpage>
<self-uri xlink:href="pnas.201617259.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Parkinson’s disease (PD) is an incurable neurodegenerative disorder characterized by motor and nonmotor deficits, including cognitive decline and dementia. The protein αSyn is strongly associated with PD pathogenesis, whereas αSyn mutations, such as p.A53T, cause familial forms of PD. Animal models are crucial for understanding PD pathogenesis, but there are limitations in the extent to which these models reproduce faithfully the human disease. Cell-reprogramming technologies allow the generation of human neurons from patients with PD, but it has proven difficult to identify cellular pathologies in induced pluripotent stem cell–derived neurons. In this study, we created a robust p.A53T patient–derived model of PD that captures disease-related phenotypes under basal conditions, thus providing a unique system for studies of disease mechanisms and development of therapeutics.</p>
</abstract>
<abstract>
<p>α-Synuclein (αSyn) is the major gene linked to sporadic Parkinson’s disease (PD), whereas the G209A (p.A53T) αSyn mutation causes a familial form of PD characterized by early onset and a generally severe phenotype, including nonmotor manifestations. Here we generated de novo induced pluripotent stem cells (iPSCs) from patients harboring the p.A53T mutation and developed a robust model that captures PD pathogenic processes under basal conditions. iPSC-derived mutant neurons displayed novel disease-relevant phenotypes, including protein aggregation, compromised neuritic outgrowth, and contorted or fragmented axons with swollen varicosities containing αSyn and Tau. The identified neuropathological features closely resembled those in brains of p.A53T patients. Small molecules targeting αSyn reverted the degenerative phenotype under both basal and induced stress conditions, indicating a treatment strategy for PD and other synucleinopathies. Furthermore, mutant neurons showed disrupted synaptic connectivity and widespread transcriptional alterations in genes involved in synaptic signaling, a number of which have been previously linked to mental disorders, raising intriguing implications for potentially converging disease mechanisms.</p>
</abstract>
<kwd-group>
<kwd>α-synuclein</kwd>
<kwd>axonal degeneration</kwd>
<kwd>dystrophic neurites</kwd>
<kwd>Parkinson’s disease</kwd>
<kwd>small molecules</kwd>
</kwd-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>